insights_auto
Why is SABS down 3.23%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
$3.00
arrow_downward
-3.23%(-0.100) 1D
Nov 10, 1:48:50 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
$3.07
High
$3.14
Low
$2.96
Mkt. cap
270.27M
Avg. vol.
645.67K
Volume
509.64K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
Open
$3.07
High
$3.14
Low
$2.96
Mkt. cap
270.27M
Avg. vol.
645.67K
Volume
509.64K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
News stories
From web sources and news partners
Yahoo Finance
·
57 minutes ago
Is the S&P 500 Heading for a Correction?
Traders Union
·
1 hour ago
Nasdaq 100 declines amid seller pressure and risk of further losses toward 27,342 support
www.tmgm.com
·
2 hours ago
Can Dow Jones Futures Extend Gains as Inflation Data and Tech Earnings Come into Focus?
24/7 Wall St.
·
1 hour ago
Apple Turned $1,000 Into $13,805 in Ten Years, More Than Three Times What the S&P 500 Delivered
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Florida, United States
SectorHealth Care
IndustryBiotechnology
Websitesab.bio